1)Gologorsky D, Thanos A, Vavvas D:Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm PMID:23028203, 2012
2)Powell EU, Field R:Diabetic retinopathy and rheumatoid arthritis. Lancet 284:17-18, 1964
3)Jin M, Kashiwagi K, Iizuka Y et al:Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina 21:28-33, 2001
4)Yuuki T, Kanda T, Kimura Y et al:Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications 15:257-259, 2001
5)Saito M, Barbazetto IA, Spaide RF:Intravitreal cellular infiltrate imaged as punctate spots by spectral-domain optical coherence tomography in eyes with posterior segment inflammatory disease. Retina 33:559-565, 2013
6)Korot E, Comer G, Steffens T et al:Algorithm for the measure of vitreous hyperreflective foci in optical coherence tomographic scans of patients with diabetic macular edema. JAMA Ophthalmol 134:15-20, 2016
7)Urbančič M, Kloboves PV, Petrovič D et al:A flow cytometric analysis of vitreous inflammatory cells in patients with proliferative diabetic retinopathy. Biomed Res Int 25:1528, 2013
8)Adamiec MJ, Oficjalska MJ:Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes—role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 246:1665-1670, 2008
scoring of murine experimental autoimmune uveoretinitis using optical coherence tomography. PLoS One 8:e63002, 2013
10)Funatsu H, Noma H, Mimura T et al:Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116:73-79, 2009